Phase

Preclinical & Translational

Once programs leave pure discovery, the demands change. Biology must withstand pressure. Evidence must connect molecular findings to real outcomes. This is where translational clarity sets the tone for the rest of the development.

What companies need at this stage

Teams aim to understand mechanisms, build predictive biomarkers, and design preclinical studies that can be translated. They need confidence that what works in model systems will hold true in human biology.

BioLizard solutions

  • Deep multi-omics integration to unite transcriptomics, proteomics, metabolomics, and clinical annotations.
  • Mechanism of action analysis through pathway, network, and causal tools.
  • PK and PD biomarker frameworks that stand up in later phases.
  • Animal to human translation models that preserve biological meaning.
  • QC and validated workflows ready for IND packages.

 

Relevant Bio|Verse® modules

Bio|Mx® anchors translational insight. Dashboards let teams track biomarkers, explore mechanistic patterns, and compare preclinical and human data.

Explore →

Modular offerings

Multi-omics modeling | Digital twin simulations | Proteomics and metabolomics pipelines | IND and IMPD data structures

Explore all solutions →

 

Omics-driven diagnostics in animals

Omics-driven diagnostics in animals

Chronic diseases are a burden for companion animals, but can be managed better if diagnosed early. Multi-omics analysis is complex, but offers opportunities to discover novel biomarker panels.